hemotune recognized as innovation leader in blood purification technology

hemotune’s hard work and effort in developing therapeutic blood purification platform has been recognized by leading market research and consulting company Frost & Sullivan. Awarding hemotune with Technology Leadership Award in Blood Purification Technology, they shared: “Given today’s landscape, Frost & Sullivan believes the company is in a prime position to disrupt the blood purification market.” 


Media Release_Frost Sullivan



HEMEX is a global provider of clinical research services to small and medium-sized life sciences companies in diverse therapeutic areas. By combining extensive clinical expertise, commitment to speed, and dedication to patient-centric approaches, HEMEX supports its clients to complete their clinical trials faster. Advancing healthcare and improving patient outcomes, HEMEX’s priority is ensuring patients can have access to lifesaving therapies within a short clinical journey. Through its subsidiaries, Hemex Germany GmbH and Hemex Benelux AV, the company can also secure project funding through different EU funds. For more information, visit https://hemex.ch/